Design and functionalities of the MADOR® software suite for dose-reduction management after DTPA therapy
B Leprince1, P Fritsch2, P Bérard3
1CEA/DSV/iRCM 18 route du Panorama, BP 6, F-92265 Fontenay-aux-Roses, France bruno.leprince@cea.fr.
Abstract:
A software suite on biokinetics of radionuclides and internal dosimetry intended for the occupational health practitioners of nuclear industry and for expert opinions has been developed under Borland C++ Builder™. These computing tools allow physicians to improve the dosimetric follow-up of workers in agreement with the French regulations and to manage new internal contaminations by radionuclides such as Pu and/or Am after diethylene triamine penta-acetic acid treatments. In this paper, the concept and functionalities of the first two computing tools of this MADOR(®) suite are described. The release 0.0 is the forensic application, which allows calculating the derived recording levels for intake by inhalation or ingestion of the main radioisotopes encountered in occupational environment. Indeed, these reference values of activity are convenient to interpret rapidly the bioassay measurements and make decisions as part of medical monitoring. The release 1.0 addresses the effect of DTPA treatments on Pu/Am biokinetics and the dose benefit. The forensic results of the MADOR(®) suite were validated by comparison with reference data.
Related Concept Videos
Dosage Regimens: Designs and Approaches
Modified-Release Drug Delivery Systems: Rate-Programmed I
Therapeutic Drug Monitoring: Overview and Classification
Dosage Regimen Designs: Nomograms and Tabulations
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Drug Analysis Methods


